KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Taxes (2016 - 2025)

Globus Medical's Current Taxes history spans 15 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Current Taxes fell 61.26% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, down 61.26%, while the annual FY2025 figure was $4.2 million, 61.26% down from the prior year.
  • Current Taxes reached $4.2 million in Q4 2025 per GMED's latest filing, down from $48.0 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $48.0 million in Q3 2025 to a low of $990000.0 in Q4 2022.
  • Average Current Taxes over 5 years is $16.0 million, with a median of $9.6 million recorded in 2021.
  • Peak YoY movement for Current Taxes: skyrocketed 2530.12% in 2023, then tumbled 87.87% in 2024.
  • A 5-year view of Current Taxes shows it stood at $6.4 million in 2021, then crashed by 84.57% to $990000.0 in 2022, then surged by 2296.57% to $23.7 million in 2023, then crashed by 54.8% to $10.7 million in 2024, then plummeted by 61.26% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Current Taxes are $4.2 million (Q4 2025), $48.0 million (Q3 2025), and $38.9 million (Q2 2025).